Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Effect of Lipopolysaccharide on Toll-Like Receptor-4 Signals in Mouse Cancer Cells Publisher Pubmed



Dana N1 ; Javanmard SH2 ; Vaseghi G3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Applied Physiology Research Centre, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Physiology, Applied Physiology Research Centre, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Isfahan Cardiovascular Research Centre, Department of Pharmacology, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Bratislava Medical Journal Published:2017


Abstract

BACKGROUND: Recent findings showed that activated TLR signals on cancer cells might promote cancer progression. This study was designed to explore the influence of Toll-like receptor 4 (TLR4) agonist lipopolysaccharides (LPS) on mouse melanoma and breast cancer cell proliferation and their TLR4 signalling. METHODS: Mouse melanoma cell line (B16F10) and breast cancer cell line (4T1) were taken as models. They were treated with LPS (0, 1.25, 2.5, 5, 7.5, 10 μg/ml) for 4, 16, 24, 48 h and MTT assay was done. The expression of TLR4, MyD88, NF-κB mRNA was detected by quantitative real time-polymerase chain reaction method quantitatively. RESULTS: Ultra-pure LPS at 5 μg/ml concentration increased significantly B16F10 cell viability 24 hour after stimulation, but not in 4T1 cell. The mRNA levels of TLR4, MyD88 and NF-κB were significantly up-regulated in both cell lines by stimulating the cells at 5 μg/ml LPS. CONCLUSIONS: Our data demonstrated that B16F10 and 4T1 cells are responsive to LPS, but their responses are time and dose dependent. These results provide new ways to understand the TLR4 signalling in tumour cells.
Related Docs
View other Related Docs
1. Ppar Γ Agonist, Pioglitazone, Suppresses Melanoma Cancer in Mice by Inhibiting Tlr4 Signaling, Journal of Pharmacy and Pharmaceutical Sciences (2019)
2. Morphine Upregulates Toll-Like Receptor 4 Expression and Promotes Melanomas in Mice, Immunopharmacology and Immunotoxicology (2023)
3. Activation of Pparγ Inhibits Tlr4 Signal Transduction Pathway in Melanoma Cancer in Vitro, Advanced Pharmaceutical Bulletin (2020)
4. The Effect of Fenofibrate, a Pparα Activator on Toll-Like Receptor-4 Signal Transduction in Melanoma Both in Vitro and in Vivo, Clinical and Translational Oncology (2020)
5. Effects of the Co-Administration of Morphine and Lipopolysaccharide on Toll-Like Receptor-4/Nuclear Factor Kappa Β Signaling Pathway of Mda-Mb-231 Breast Cancer Cells, Advanced Biomedical Research (2023)
6. M2000 (Β-D-Mannuronic Acid) As a Novel Antagonist for Blocking the Tlr2 and Tlr4 Downstream Signalling Pathway, Scandinavian Journal of Immunology (2017)
7. The Potential Interplay Between Opioid and the Toll-Like Receptor 4 (Tlr-4), Immunopharmacology and Immunotoxicology (2023)
8. Influence of Morphine on Tlr4/ Nf-Kb Signaling Pathway of Mcf-7 Cells, Bratislava Medical Journal (2018)
Experts (# of related papers)
View all Related Experts
Shaghayegh Haghjooy Javanmard (10)
Golnaz Vaseghi (10)
Other Related Docs
9. The Effect of Lipopolysaccharide on the Expression Level of Immunomodulatory and Immunostimulatory Factors of Human Amniotic Epithelial Cells, BMC Research Notes (2018)
10. Down-Regulation of Inflammatory Signaling Pathways Despite Up-Regulation of Toll-Like Receptors; the Effects of Corticosteroid Therapy in Brain-Dead Kidney Donors, a Double-Blind, Randomized, Controlled Trial, Molecular Immunology (2018)
11. Combined All-Extremity High-Intensity Interval Training Regulates Immunometabolic Responses Through Toll-Like Receptor 4 Adaptors and A20 Downregulation in Obese Young Females, Obesity Facts (2020)
12. Crosstalk Between Peroxisome Proliferator-Activated Receptors and Toll-Like Receptors: A Systematic Review, Advanced Pharmaceutical Bulletin (2019)
13. The Expression of Toll-Like Receptors (Tlrs) in Testicular Cancer: A Case Control Study, International Journal of Reproductive BioMedicine (2013)
14. The Role of Toll Like Receptors in Pregnancy, International Journal of Fertility and Sterility (2013)
15. Morphine Promotes Migration and Lung Metastasis of Mouse Melanoma Cells, Brazilian Journal of Anesthesiology (English Edition) (2023)
16. Toll-Like Receptors and Diabetic Nephropathy: A Review of Recent Advances, Turkish Journal of Immunology (2024)
17. Don't Eat Me/Eat Me Signals As a Novel Strategy in Cancer Immunotherapy, Heliyon (2023)
18. The Effects of Morphine on Vascular Cell Adhesion Molecule 1(Vcam-1) Concentration in Lung Cancer Cells, Archives of Physiology and Biochemistry (2023)
19. Modulatory Effects of Thymol and Carvacrol on Inflammatory Transcription Factors in Lipopolysaccharide-Treated Macrophages, Journal of Immunotoxicology (2016)
20. Introduction of a New Recombinant Vaccine Based on Grp78 for Breast Cancer Immunotherapy and Evaluation in a Mouse Model, BioImpacts (2023)
21. The Effect of Cyclophosphamide on Tlr2 Gene Expression in Balb/C Mice With Systemic Candidiasis, Journal of Isfahan Medical School (2016)
22. Toll‑Like Receptor 4, 2, and Interleukin 1 Receptor Associated Kinase4: Possible Diagnostic Biomarkers in Myelodysplastic Syndrome Patients, Advanced Biomedical Research (2024)